Femasys Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
The company stated in the following report that they exploit animals for product testing.
“We completed two animal studies to support efficacy of the occlusion, or blockage, created by the biopolymer tissue adhesive, a degradable blend of cyanide derivatives of acrylates, we use in our FemBloc system. The first was an exploratory study of efficacy in the rabbit model, where the rabbit oviducts mimic human female fallopian tubes.” (Page 86) Read the full document
Femasys Inc. is a biomedical company focused on transforming women’s healthcare. The Company is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics.
Company Website: https://femasys.com